<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
  <title>ilovemitochondria.com</title>
  <link>https://ilovemitochondria.com/</link>
  <description>A personal blog by Offer Shina about mitochondria and VDAC1 — the science, the news, and why a PSEN1 carrier can't stop reading about it.</description>
  <language>en</language>
  <item>
    <title>In septic T cells, VDAC1 oligomers open a pore that leaks mtDNA and drives inflammation — and VBIT-12 shuts it down</title>
    <link>https://ilovemitochondria.com/news/vdac1-tcell-inflammation/</link>
    <guid>https://ilovemitochondria.com/news/vdac1-tcell-inflammation/</guid>
    <pubDate>Wed, 22 Jul 2026 00:00:00 GMT</pubDate>
    <description>A Shanghai team watched VDAC1 clump up, leak mtDNA, and trip the cGAS–STING alarm in immune cells — and calmed the whole thing down with the oligomerization blocker VBIT-12.</description>
    <category>VDAC1</category><category>inflammation</category><category>mtDNA</category><category>cGAS-STING</category><category>VBIT</category><category>sepsis</category>
  </item>
  <item>
    <title>So what actually is VDAC1, and why do I care this much?</title>
    <link>https://ilovemitochondria.com/posts/what-is-vdac1/</link>
    <guid>https://ilovemitochondria.com/posts/what-is-vdac1/</guid>
    <pubDate>Sun, 12 Jul 2026 00:00:00 GMT</pubDate>
    <description>The on-ramp post: what the channel does, why 'the most abundant protein on the mitochondrial outer membrane' is a big deal, and how the same pore that keeps a cell alive can help kill it — with a spin-it-yourself 3D structure.</description>
    <category>VDAC1</category><category>mitochondria</category><category>explainer</category><category>VBIT</category>
  </item>
  <item>
    <title>A mitochondria-targeting nanozyme restarts mitophagy in cartilage and switches off mtDNA-driven inflammation in osteoarthritis</title>
    <link>https://ilovemitochondria.com/news/osteoarthritis-nanozyme/</link>
    <guid>https://ilovemitochondria.com/news/osteoarthritis-nanozyme/</guid>
    <pubDate>Fri, 10 Jul 2026 00:00:00 GMT</pubDate>
    <description>Bioengineers at Shanghai Ninth People's Hospital built a mitochondria-targeting nanozyme that mops up damage in cartilage cells, restarts mitophagy, and shuts down the mtDNA→cGAS/STING inflammation loop in osteoarthritis.</description>
    <category>mitophagy</category><category>mtDNA</category><category>cGAS-STING</category><category>nanomedicine</category>
  </item>
  <item>
    <title>Mendelian randomization flags specific mitochondrial genes as likely causal in acute and chronic kidney disease</title>
    <link>https://ilovemitochondria.com/news/kidney-mitochondria-genes/</link>
    <guid>https://ilovemitochondria.com/news/kidney-mitochondria-genes/</guid>
    <pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate>
    <description>A Sichuan group cross-referenced the whole MitoCarta gene inventory against genetics of acute and chronic kidney disease and pulled out a handful of mitochondrial genes that look causal.</description>
    <category>mitochondria</category><category>genetics</category><category>kidney</category>
  </item>
  <item>
    <title>VBIT-4 &amp; VBIT-12: the molecules trying to stop VDAC1 from ganging up</title>
    <link>https://ilovemitochondria.com/posts/vbit-4-and-vbit-12/</link>
    <guid>https://ilovemitochondria.com/posts/vbit-4-and-vbit-12/</guid>
    <pubDate>Wed, 08 Jul 2026 00:00:00 GMT</pubDate>
    <description>A running summary of the VBIT compounds that block VDAC1 oligomerization — where the idea came from, which disease models they've been tested in, and the honest caveats about how early it all still is.</description>
    <category>VBIT</category><category>VDAC1</category><category>mtDNA</category><category>drug-watch</category>
  </item>
  <item>
    <title>Why a PSEN1 carrier ended up obsessed with mitochondria</title>
    <link>https://ilovemitochondria.com/posts/why-this-blog/</link>
    <guid>https://ilovemitochondria.com/posts/why-this-blog/</guid>
    <pubDate>Fri, 03 Jul 2026 00:00:00 GMT</pubDate>
    <description>The origin story of this blog — a genetic result, the amyloid-vs-energy argument in Alzheimer's, and the hunch that mitochondria are doing more of the driving than we give them credit for.</description>
    <category>personal</category><category>mitochondria</category><category>neurodegeneration</category><category>VDAC1</category>
  </item>
  <item>
    <title>Danshen (Salvia miltiorrhiza) eases lung fibrosis in rats by restoring PINK1/Parkin mitophagy in fibroblasts</title>
    <link>https://ilovemitochondria.com/news/salvia-lung-fibrosis/</link>
    <guid>https://ilovemitochondria.com/news/salvia-lung-fibrosis/</guid>
    <pubDate>Fri, 26 Jun 2026 00:00:00 GMT</pubDate>
    <description>A Shanghai team showed danshen (Salvia miltiorrhiza) eases lung fibrosis in rats by nudging fibroblasts to run mitophagy through the PINK1/Parkin pathway.</description>
    <category>mitophagy</category><category>PINK1-Parkin</category><category>fibrosis</category>
  </item>
  <item>
    <title>x-tosis lands a $2.74M Michael J. Fox Foundation grant to push XTS001 — a brain-penetrant VDAC1-oligomerization blocker — toward Parkinson's</title>
    <link>https://ilovemitochondria.com/news/x-tosis-mjff-grant/</link>
    <guid>https://ilovemitochondria.com/news/x-tosis-mjff-grant/</guid>
    <pubDate>Wed, 24 Jun 2026 00:00:00 GMT</pubDate>
    <description>The most conflicted post on the site, flagged as such: x-tosis — the biotech I co-founded — just won a $2.74M grant from The Michael J. Fox Foundation to advance XTS001, an oral, brain-penetrant molecule that blocks VDAC1 oligomerization, into Parkinson's development.</description>
    <category>VDAC1</category><category>VBIT</category><category>neurodegeneration</category><category>Parkinson's</category><category>x-tosis</category><category>company</category>
  </item>
  <item>
    <title>Review: forcing ER-to-mitochondria calcium overload through the IP3R–GRP75–VDAC1 relay as a way to kill cancer cells</title>
    <link>https://ilovemitochondria.com/news/calcium-er-mito-review/</link>
    <guid>https://ilovemitochondria.com/news/calcium-er-mito-review/</guid>
    <pubDate>Mon, 22 Jun 2026 00:00:00 GMT</pubDate>
    <description>A Yantai University review maps calcium overload as a cancer-killing strategy — how the ER and mitochondria trade calcium across their contact sites, with VDAC1 sitting in the middle of the relay.</description>
    <category>VDAC1</category><category>calcium</category><category>cancer</category><category>review</category>
  </item>
  <item>
    <title>Bladder cancer resists cisplatin by tagging VDAC1 for mitophagy — blocking that pathway restores the drug's punch</title>
    <link>https://ilovemitochondria.com/news/bladder-cancer-mitophagy/</link>
    <guid>https://ilovemitochondria.com/news/bladder-cancer-mitophagy/</guid>
    <pubDate>Mon, 15 Jun 2026 00:00:00 GMT</pubDate>
    <description>A Southern Medical University team found bladder-cancer cells survive cisplatin by tagging VDAC1 for destruction and switching on mitophagy — block that escape hatch and the drug bites again.</description>
    <category>VDAC1</category><category>mitophagy</category><category>cancer</category>
  </item>
  <item>
    <title>In uveal melanoma, VDAC1 helps keep the tumour's genome stable — silencing it kills cells and unleashes DNA damage</title>
    <link>https://ilovemitochondria.com/news/vdac1-uveal-melanoma/</link>
    <guid>https://ilovemitochondria.com/news/vdac1-uveal-melanoma/</guid>
    <pubDate>Tue, 26 May 2026 00:00:00 GMT</pubDate>
    <description>Screening uveal melanoma for genes tied to DNA–RNA tangles, a Yichang team found VDAC1 near the top — and switching it off both killed tumour cells and scrambled their genome.</description>
    <category>VDAC1</category><category>cancer</category><category>genome-stability</category>
  </item>
</channel></rss>
